Soumitra Ghosh
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$6.3MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $6.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 11, 2022 | NIH | SBIR Phase II Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | $2.1M | AVEXEGEN THERAPEUTICS INC. |
| Feb 15, 2021 | NIH | SBIR Phase II Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | $2.9M | AVEXEGEN THERAPEUTICS INC. |
| Feb 3, 2021 | NIH | SBIR Phase II Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | $868K | AVEXEGEN THERAPEUTICS INC. |
| Sep 20, 2016 | NIH | SBIR Phase I Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | $225K | AVEXEGEN THERAPEUTICS INC. |
| Sep 16, 2016 | NIH | SBIR Phase I Neuregulin-4: A Novel Therapy for Inflammatory Bowel Disease | $225K | AVEXEGEN THERAPEUTICS INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#167
Awards as PI#417
Patents#273
Companies
- AVEXEGEN THERAPEUTICS INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.